Back to Atlas
CTransientStandard research/education caution
CMP-0433
Research/gray-market; prohibited in sport
RAD-150 / TLB-150
Ergogenic / SARM-adjacent
Performance/muscle-building gray-market positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SARM analog
- Primary mechanism
- RAD-140 ester/analog marketed as longer-acting AR modulator
- Primary market use
- Performance misuse
Pharmacology
- Molecular weight (Da)
- Not consistently disclosed
- Oral bioavailability
- Unknown; marketed oral
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Gray-market
- Clinical status
- Research/gray-market; prohibited in sport
- Value-for-money score
- 1 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Often marketed without robust public PK or clinical data